Invyncible review
Invyncible will sell a working mom either cheaper compounded semaglutide ($192.50/mo against a $275.00 reference price) or tirzepatide ($210/mo against $300.00), or an FDA-approved Wegovy ($1,750/mo) or Zepbound ($1,540/mo) pen, on the same account — genuinely useful if your needs change — but it won't confirm your state's availability until you're already in the intake, and it discloses its corporate parent and street address rather than hiding behind a trade name, a LegitScript seal displayed alongside it.
- HSA / FSA-eligible
- Editor-vetted
- No insurance needed
Invyncible at a glance
- Semaglutide
- $192.50/mo
- Tirzepatide
- $210/mo
- Coverage
- Not publicly disclosed; confirmed during intake
- Start
- Not disclosed
How we scored Invyncible
Each factor is scored from Invyncible's real pricing, disclosures and intake flow, then combined into the 53/100 Rx-Readiness Score by the same weighted six-factor framework we apply to every provider — never nudged by whether a provider pays us.
No turnaround time published on the programs pages checked.
Prices are specific but framed as a permanent 'sale' against an inflated reference price rather than a plain flat rate.
No video-visit requirement described; async not explicitly confirmed either.
No state list published; availability confirmed only during intake.
Both molecules AND FDA-approved brand-name Wegovy/Zepbound sold on the same account — the most flexible molecule access checked this round.
'Cancel anytime, no long-term commitment' stated in its own FAQ.
How we verified this review
- Last verified
- August 2026
- Confidence
- medium
- Primary source
- www.invyncible.com/semaglutide-programs
Florida-based; discloses its corporate parent and street address, plus a LegitScript seal. Every price on its programs pages reads as a permanent 'sale' against a higher reference price rather than a limited-time promo, so the sale figure is recorded as the standing price since it's what the checkout flow actually uses. Sells both compounded programs and FDA-approved brand Wegovy/Zepbound on the same account. No state list published. No FDA warning letter found for Invyncible in a dedicated search or WLR's consolidated enforcement index.
Pricing
Prices re-verified
| Medication | Monthly | Plan |
|---|---|---|
| Compounded semaglutide | $192.5 | Standard FormulaPriced at $192.50 against a $275.00 reference figure. Add-on Glycine/B12 tiers run $149–$262.50/mo; brand-name Wegovy is sold direct at $1,750/mo (vs. $2,500 list). |
| Compounded tirzepatide | $210 | Standard FormulaPriced at $210.00 against a $300.00 reference figure. Add-on tiers run $180–$260/mo; brand-name Zepbound is sold direct at $1,540/mo (vs. $2,200 list). |
Swipe the table to see plan details →
HSA/FSA is commonly accepted for GLP-1 telehealth — check your plan. Prices reflect Invyncible's public disclosures at last review and change often; confirm the current number on Invyncible's own site.
What we like
- Names its corporate parent and a physical address rather than an anonymous storefront
- LegitScript-verified
- Both compounded programs and FDA-approved brand Wegovy/Zepbound on one account
- No long-term commitment; cancel anytime per its own FAQ
The caveats
- No state-availability list — confirmed only during intake
- No published time-to-first-dose
- Every price is displayed as a permanent 'sale' against a higher reference figure that never appears to actually apply
- Brand-name pricing ($1,540–$1,750/mo) still runs well above most insurance-backed options
Invyncible for working moms: our verdict
Invyncible will sell a working mom either cheaper compounded semaglutide ($192.50/mo against a $275.00 reference price) or tirzepatide ($210/mo against $300.00), or an FDA-approved Wegovy ($1,750/mo) or Zepbound ($1,540/mo) pen, on the same account — genuinely useful if your needs change — but it won't confirm your state's availability until you're already in the intake, and it discloses its corporate parent and street address rather than hiding behind a trade name, a LegitScript seal displayed alongside it. It runs about $192.5/month.
We weigh Invyncible the way working moms actually have to: not just the monthly line on your budget, but how fast you can start without a scheduled video visit and a flat monthly price that doesn't climb as your dose does — the parts a generic weight-loss review skips.
What Invyncible actually costs
- Compounded semaglutide — Standard Formula: $192.5/mo
- Compounded tirzepatide — Standard Formula: $210/mo
That's roughly in line with the ~$175/month median across our roster.
The medications Invyncible prescribes
Invyncible prescribes semaglutide and tirzepatide — the two molecules with the strongest published weight-loss outcomes, and having both on one account matters because you can switch between them without re-enrolling or hunting for a new provider mid-plan. It can route you to FDA-approved brand pens as well as compounded versions — the on-label products carry the manufacturer's own labeling, though the brand price runs well above the compounded tiers.
Where Invyncible fits — and where it doesn't — for working moms
A good fit if…
- you want a straightforward semaglutide and tirzepatide program and will confirm the details before you commit.
Look elsewhere if…
- you'd rather the most predictable place to start and pause — that's what our #1 pick, CoreAge Rx, is built for.
Trust, safety, and the fine print
Our confidence is moderate — the core facts check out, but some details (per-state availability, program mechanics) aren't fully public. As with any compounded GLP-1, the most useful thing working moms can do is confirm which licensed pharmacy fills the prescription and what's in the formulation — we explain how we weigh oversight in our scoring methodology.
One line that applies to every provider on this site: no GLP-1 is established as safe in pregnancy or while breastfeeding, and the labels advise against use. This is a review of a commercial program, not a green light — the timing decision belongs to you and your clinician.
The bottom line
Invyncible is a reasonable option — weigh it on how fast you can start without a scheduled video visit and a flat monthly price that doesn't climb as your dose does against the alternatives below. For most working moms, CoreAge Rx remains the stronger all-round fit — see why it tops our ranking.
The bottom line for working moms
Best for: A mom who wants the option to start compounded and later move to a brand-name pen without switching providers.
Alternatives to Invyncible
Providers we have a referral relationship with, ordered by Rx-Readiness Score — highest first. A fee never moves a score, but it does decide who appears here, so this is not the full list: see the complete ranking.
- Visit CoreAge RxRx-Readiness95100CoreAge RxOur #1 pick
The shortlist pick: one flat price that doesn't climb as your dose does, both molecules on a single plan, and a nationwide async intake you can finish on a break.
- Visit Trimi HealthRx-Readiness88100
The price-first partner: some of the lowest flat, all-inclusive compounded pricing we track, nationwide and async — strong if the monthly number is your deciding factor and you read the annual-prepay fine print.
- Visit Telos RxRx-Readiness86100
A fast, fully async start with a needle-free sublingual tirzepatide option and — a genuine upgrade since our last check — flat pricing stated in writing. The catch is a state list it still won't publish.
Keep comparing Invyncible
Head-to-head & alternatives
Invyncible, answered
- How much does Invyncible cost?
- As last verified, Invyncible's compounded pricing starts around $192.5/month ($192.50/mo semaglutide, $210/mo tirzepatide). Confirm the current, all-in price on Invyncible's own site before you commit.
- Can I start Invyncible without a scheduled video visit?
- Invyncible involves more clinician touchpoints (and, in some cases, a scheduled visit), so it isn't the fastest async start. If a no-video signup is your priority, our #1 pick is built for it.
- Does Invyncible offer both semaglutide and tirzepatide?
- Yes — Invyncible offers both molecules, so you can switch without re-enrolling. Tirzepatide's dual GIP/GLP-1 action posts the strongest published weight-loss numbers.
- Where does Invyncible rank for working moms?
- Invyncible scores 53/100 on our Rx-Readiness Score (rank #119), which weights six factors led by speed to first dose and flat pricing. Our #1 pick, CoreAge Rx, leads the ranking — see how they compare.
Pricing, states and verification reflect Invyncible's public disclosures at last review; the Rx-Readiness Score is our editorial judgment per the published methodology. This is background reading, not medical advice — GLP-1 medications are not established as safe in pregnancy or breastfeeding. See our medical disclaimer and how we're funded.